Literature DB >> 15273888

[Trimetazidine-induced parkinsonism].

J F Martí Massó1.   

Abstract

Eight patients, six women and two men, ages between 72 and 94 years (mean age 80), suffered from parkinsonism while taking trimetazidine, seven of them for a 6 to 12 months time period and the other for 9 years. The parkinsonism reverted after drug withdrawal. This is the first report of trimetazidine induced parkinsonism. It is important to know this side effect in order to avoid its administration to patients with any parkinsonism, especially those suffering dementia with Lewy bodies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273888

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  3 in total

1.  The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson's Disease.

Authors:  Dávid Pintér; Annamária Juhász; Márk Harmat; József Janszky; Norbert Kovács
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

2.  Trimetazidine-Induced Parkinsonism: A Systematic Review.

Authors:  Anna Marielle B Dy; Lorenzo Luis G Limjoco; Roland Dominic G Jamora
Journal:  Front Neurol       Date:  2020-02-25       Impact factor: 4.003

3.  Trimetazidine Use and the Risk of Parkinsonism: A Nationwide Population-Based Study.

Authors:  Seungyeon Kim; Yun Mi Yu; Jeongyoon Kwon; Kyeong Hye Jeong; Jeong Sang Lee; Euni Lee
Journal:  Int J Environ Res Public Health       Date:  2020-10-04       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.